Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Carcinoma

Explore clinical trials studying Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

412 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Renal Cell Carcinoma trial results

Completed

Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib

NCT00474786

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations
  • Pfizer Investigational Site Duarte, California, United States
  • Pfizer Investigational Site La Jolla, California, United States
  • Pfizer Investigational Site La Jolla, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
View all 128 locations
View Trial Details
Completed

Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

NCT00876382

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Gulfcoast Oncology Associates St. Petersburg, Florida, United States
  • Medical Oncology Associates of Augusta Augusta, Georgia, United States
  • Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States
View Trial Details
Completed

A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors

NCT01100619

Conditions
Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +25 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

NCT00678119

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • The Urology Center of Colorado Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
View all 14 locations
View Trial Details
Completed

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

NCT00944905

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Emory University Winship Cancer Center Atlanta, Georgia, United States
  • The University of Chicago Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer

NCT00272649

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • UCLA Kidney Cancer Program Los Angeles, California, United States
  • Univ. of Colorado Health Science Center - Division of Medical Oncology Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • The Indiana University Cancer Center/IUPUI Indianapolis, Indiana, United States
View Trial Details
Completed

RNA-Loaded Dendritic Cell Cancer Vaccine

NCT00087984

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • University of California - Irvine Orange, California, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details

Related conditions